Facebook
Twitter
LinkedIn
Forward
The Department of Pediatrics Research Week 2023
The Department of Pediatrics’ annual Research Week will be held virtually May 15-19, 2023. Through a mix of live-streamed lectures, in-person events and interactive sessions, members of the Department of Pediatrics and the entire University of Wisconsin–Madison community can hear the latest advances in pediatric research.
Activities for the week include small group sessions with faculty and trainees, the second annual Fellows Capstone Presentations, the distinguished Gerard B. Odell Lecture, the Wald Faculty Research Forum and Town Hall, Keynote Lecture, platform presentations, and an in-person poster session with reception featuring the research of residents, fellows, faculty, and staff.
Intended Audience
The target audience for this activity is physicians, nurses, researchers, and students in the Department of Pediatrics who participate in research activities.
Learning Objectives
By participating in the is activity, members of the healthcare team will be able to:
- Discuss mechanisms for incorporating scholarly research into one's own research projects
- Identify best practices for developing Mentor and Mentee relationships to enhance and grow research projects across disciplines
- Demonstrate how QI initiatives and research directly impact health care disparities and patient outcomes
- Collaborate with faculty, staff, and trainees across disciplines to identify best practices in research
- Examine best practices for including diversity, equity and inclusion standards into scholarly work and research projects
Elements of Competence
This educational activity is designed to change learner competence and focuses on the following competencies:
- Accreditation Council for Graduate Medical Education (ACGME)/Nursing: Patient Care and Procedural Skills, Systems-based Practice
- National Academy of Medicine (NAM)/Nursing: Employ Evidence-based Practice
- Interprofessional Education Collaborative Competencies: Values and Ethics, Roles and Responsibilities, Interprofessional Communication
- Diversity, Equity, and Inclusion: Address Health Disparities, Value Diversity in the Clinical Encounter
| Monday, May 15 | |
|---|---|
| 8:00 am - 9:00 am Hybrid | Medical Education Scholars in Pediatrics Sushant Srinivasan |
| 12:00 pm - 1:00 pm Zoom | Global Health and Research |
| Tuesday, May 16 | |
| 8:00 am - 9:00 am Hybrid | Mentoring |
| 1:30 pm - 5:00 pm | Fellow Capstone Research Presentations |
| Wednesday, May 17 | |
| 8:00 am - 9:00 am Hybrid | QI: Inpatient Hyperbilirubinemia Laura Chen, MD and Elizabeth Goetz, MD, MPH |
| 12:00 pm - 1:00 pm Zoom | DEI & Scholarly Workshop Emily Ruedinger, MD, MEd |
| Thursday, May 18 | |
| 7:30 am - 8:30 am Hybrid | Odell Lecture 2023 Stephen Meyn, MD, PhD |
| 8:30 am - 9:30 am Hybrid | Odell Award Recipient and Presentation (8:30-9:00) |
| 9:40 am - 12:30 pm Hybrid | Ellen Wald Faculty Research Forum and Town Hall |
| Friday, May 19 | |
| 1:00 pm - 1:30 pm Hybrid | Research Week Keynote Presentation Anna Huttenlocher, MD |
| 1:30 pm - 3:00 pm | Platform Presentations |
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
| Victoria Adkins | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Elena Alfaro | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| YAW Asamoa-Bonsu | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Najla Ba Sharahil | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| ADAM BAUER | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Arij Beshish | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Rebecca Bound | Planner | No relevant financial relationships to with ineligible companies disclose | No |
| SABRINA BUTTERIS | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| PELIN CENGIZ | Faculty | No relevant financial relationships to with ineligible companies disclose | Yes |
| LAURA CHEN | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| SUDARSHAWN DAMODHARAN | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Doug Dean III | Planner | No relevant financial relationships to with ineligible companies disclose | No |
| Johnathan Ebben | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Courtney Gaberino | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| ANTHONY GARCIA-PRATS | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Jim Gern | Planner | Gossamer Bio (Contractor), AstraZeneca (Contractor), Via Nova Therapeutics, Inc. (Contractor), MeissaVaccines Inc. (Contractor) | No |
| ELIZABETH GOETZ | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| MATTHEW HARER | Faculty | No relevant financial relationships to with ineligible companies disclose | Yes |
| TAYLOR HOUSE | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| ANNA HUTTENLOCHER | Faculty | No relevant financial relationships to with ineligible companies disclose | Yes |
| Michelle Kelly | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Cathy Lee-Miller | Planner | No relevant financial relationships to with ineligible companies disclose | No |
| Janet Legare | Faculty | BioMarin Pharmaceutical (Contractor) | No |
| TIMOTHY LIVETT | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Mala Mathur | Planner | No relevant financial relationships to with ineligible companies disclose | No |
| EMMA MOHR | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Narmin Mukhtarova | Faculty | No relevant financial relationships to with ineligible companies disclose | Yes |
| Claire O'Leary | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| KRISJON OLSON | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Adam Pfaller | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Karen Pletta | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| MICHAEL ROCK | Faculty | No relevant financial relationships to with ineligible companies disclose | Yes |
| Danielle Rodgers | Planner | No relevant financial relationships to with ineligible companies disclose | No |
| Kelsi Rogers | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| EMILY RUEDINGER | Planner | No relevant financial relationships to with ineligible companies disclose | No |
| ASHLEIGH RUSHING | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Molly Ryan | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| EMILY SCHUMACHER | Planner | No relevant financial relationships to with ineligible companies disclose | No |
| DAN SKLANSKY | Planner | No relevant financial relationships to with ineligible companies disclose | No |
| SUSHANT SRINIVASAN | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| Nicole St Clair | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
| HENRY ZAPATA GALARZA | Faculty | No relevant financial relationships to with ineligible companies disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
 | Accreditation Statement In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 14.25 ANCC contact hours.
Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.425 CEUs or 14.25 hours. | |
Available Credit
- 14.25 AMA PRA Category 1 Credit™
- 14.25 ANCC Contact Hours
- 14.25 University of Wisconsin–Madison Continuing Education Hours
- 14.25 Approved for AMA PRA Category 1 Credit™